![]() |
市場調查報告書
商品編碼
1792268
2025 年至 2033 年生育服務市場報告(依不孕症原因、程序、服務、最終使用者和地區分類)Fertility Services Market Report by Cause of Infertility, Procedure, Service, End-User, and Region 2025-2033 |
2024年,全球生育服務市場規模達461億美元。展望未來, IMARC Group預計到2033年,該市場規模將達到1,420億美元,2025-2033年期間的複合年成長率(CAGR)為12.65%。推動市場發展的因素包括:不孕症病例數的增加、個人對各種生育治療的認知度和接受度的提高,以及稅收優惠等政府優惠措施。
政府的優惠舉措
為提高生育率,上海市於 2024 年 5 月 31 日將 12 種輔助生殖技術 (ART) 納入基本醫療保險。這項措施減輕了不孕症夫婦昂貴的生育治療負擔。各國政府機構透過提供多種服務,使不孕症患者更容易取得且負擔得起生育治療。他們為體外受精 (IVF) 等生育治療提供直接財政援助或補貼。這減少了患者的自付費用,從而增加了生育服務需求。他們還投資公立生育診所,以比私人診所更低的價格提供高品質的照護。這確保了更多人,無論其經濟狀況如何,都能獲得生育服務。此外,管理部門正在建立法律框架,規範和支持生育治療,確保其安全性、合乎道德且可近性。此外,在某些國家,與生育治療相關的費用可以免稅,從而允許個人減少應稅收入並減輕這些服務的經濟負擔。
不孕不育病例不斷增加
在全球範圍內,不孕症病例的不斷增加,為生育服務市場帶來了良好的前景。由於生活方式的改變、環境影響、年齡相關問題以及疾病,人們面臨這些問題。現代飲食缺乏重要的營養素,這可能對生殖健康有害。在當今快節奏的生活方式中,高壓力普遍存在,這會導致月經週期紊亂和精子品質下降。除了導致糖尿病和高血壓等生活方式障礙外,慢性壓力也會導致不孕症問題。此外,越來越多的人出於各種原因選擇推遲生育,包括職業抱負、經濟穩定和個人目標,這為生育服務市場提供了洞察。此外,有助於治療這些問題的治療設備的需求也在增加。根據IMARC Group的研究報告,預計2032年,全球不孕症治療設備市場規模將達到7.295億美元。
提高對各種治療方法的認知和接受度
人們對各種生育治療的認知和接受度不斷提高,推動了市場的成長。世界各地的管理機構和非政府機構正在組織各種活動,旨在提高人們對各種治療方案的認知,從而促進生育服務的成長。這些活動通常利用媒體、社交平台和社區外展活動來傳播有關不孕不育原因和早期介入益處的訊息。此外,一些名人坦誠談論自己的不孕症問題以及使用試管受精、代孕或卵子冷凍等方法的案例也有助於減輕人們對這些治療方案的偏見。這種曝光激勵著其他人去探索類似的選擇,而不必擔心被他人評判。此外,市場上的主要公司正在與主要參與者建立合作夥伴關係,以擴展其服務範圍並增加生育服務市場的收入。例如,2023年4月26日,提供彈性融資計畫和禮賓支援服務的全國性家庭建設平台「未來家庭 (FF)」與北美頂級全包生殖服務提供者Prelude Network(R)達成獨家協議。此次合作將擴大高階生育服務的財務可近性,並為患者提供更多財務選擇,並使其能夠正確理解治療費用。 FF還開發了一個個人化支付選擇工具,使患者能夠根據個人治療計劃了解生育費用。
男性不孕症佔據了大部分市場佔有率
男性不孕問題可能由多種因素造成,包括不良飲食和運動習慣。卵胞漿內單一精子注射 (ICSI) 等治療方法正變得越來越普遍,尤其是在精子數量低或活力問題方面。目前有多種藥物和荷爾蒙療法可用於治療男性不孕症的特定原因,例如荷爾蒙失衡或感染。這些治療方法能夠有效解決男性不孕問題。
體外受精與卵胞漿內單一精子注射(IVF with ICSI)佔據業界最大佔有率
體外受精結合卵胞漿內單一精子注射(IVF-ICSI)對於嚴重男性不孕症患者非常有效,而傳統的IVF方法可能效果不佳。這種方法可以最大限度地提高個體受精的幾率。隨著人們尋求輔助生殖技術(ART)來克服不孕症,對IVF-ICSI等有效治療方法的需求日益成長,這為生育服務產業帶來了良好的前景。
冷凍非捐贈器官佔據主要市場佔有率
非捐贈冷凍服務是指使用來自預期母親或父母的冷凍卵子或胚胎,無需捐贈者的參與。冷凍保存技術的進步很可能推動了人們對非捐贈冷凍服務的青睞,這種技術提高了成功率,並讓患者在選擇生育治療時間方面更加靈活。玻璃化冷凍等卵子冷凍技術的進步提高了卵子在冷凍和解凍過程中的存活率。這使得冷凍卵子成為未來生育治療更可行的選擇,並展現了生育服務市場的動態。
生育診所在市場上佔據明顯主導地位
生育診所提供廣泛的治療方案,例如體外受精 (IVF)、卵胞漿內單一精子注射 (ICSI)、卵子和精子捐贈、生育力保存以及基因檢測。它們能夠提供一站式全方位服務,使其成為患者的首選。這些診所通常會根據每位患者的特定需求提供個人化治療方案,從而提高患者的滿意度。生育服務市場凸顯出,生育診所正致力於擴大其覆蓋範圍,並在各個地區建立診所網路,使更廣泛的人群能夠享受其服務。此外,這些診所配備了生殖醫學專家,包括生育專家、胚胎學家和遺傳諮詢師,以確保提供高品質的照護。它們還配備了最新的技術和實驗室設施,這對於執行先進的程序至關重要。
亞太地區引領市場,佔據最大的生育服務市場佔有率
該報告還對所有主要區域市場進行了全面分析,包括歐洲、北美、亞太地區、中東和非洲以及拉丁美洲。報告指出,亞太地區是生育服務最大的區域市場。
亞太地區匯聚了中國、印度等全球人口最多的國家。由於人口眾多,面臨不孕症問題的人數眾多,這推動了對生育服務的需求。城市化、生活方式的改變、結婚年齡的延遲以及首次生育年齡的提高,導致該地區不孕率上升。此外,生育服務業報告顯示,污染和毒素暴露等環境因素起著至關重要的作用。此外,該地區的管理部門正在鼓勵與不孕症相關的治療方案。例如,2024年,馬哈拉施特拉邦政府機構在一些選定的公立醫學院和醫院(GMCH)設立了體外受精(IVF)中心,為數千對不孕夫婦提供免費治療。此舉是為了應對馬哈拉施特拉邦總生育率(TFR)的驚人下降。
(請注意,這只是關鍵參與者的部分列表,完整列表在報告中提供。)
The global fertility services market size reached USD 46.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 142.0 Billion by 2033, exhibiting a growth rate (CAGR) of 12.65% during 2025-2033. There are several factors that are driving the market, which include rising number of infertility cases, increasing awareness and acceptance among individuals about a variety of fertility treatments, and favorable government initiatives like tax benefits.
Favorable Government Initiatives
In an effort to increase the birth rate, Shanghai integrated 12 forms of assisted reproductive technology (ART) into basic health insurance on May 31, 2024. This initiative reduced infertile couples' burden from expensive fertility treatments. Government agencies of various countries are making fertility treatments more accessible and affordable for individuals facing infertility issues by providing numerous services. They are providing direct financial assistance or subsidies for fertility treatments such as in vitro fertilization (IVF). This reduces the out-of-pocket costs for patients, thereby increasing fertility services demand. They are also investing in public fertility clinics to provide high-quality care at lower costs as compared to private clinics. This ensures that a wider range of people, regardless of their financial status, can access fertility services. In addition, governing authorities are establishing legal frameworks that regulate and support fertility treatments and ensuring that they are safe, ethical, and accessible. Furthermore, in some countries, the costs associated with fertility treatments may be tax-deductible, allowing individuals to reduce their taxable income and lessen the financial burden of these services.
Increasing Number of Infertility Cases
The growing number of infertility cases among the masses across the globe is offering a favorable fertility services market outlook. Individuals are dealing with these problems as a result of changing lifestyles, environmental influences, age-related problems, and medical ailments. Modern diets are deficient in vital nutrients, which can be harmful to reproductive health. In today's fast-paced lifestyle, high levels of stress are prevalent and can cause menstrual cycle disruption and sperm quality reduction. In addition to causing lifestyle disorders like diabetes and hypertension, chronic stress also causes infertility issues. Apart from this, the rising number of people are choosing to delay parenthood for various reasons including career aspirations, financial stability, and personal goals, which provide fertility services market insights. Furthermore, there is an increase in the demand for treatment devices that are beneficial in treating these issues among individuals. As per the research report of the IMARC Group, the global infertility treatment devices market is expected to reach US$ 729.5 Million by 2032.
Rising Awareness and Acceptance About a Variety of Treatment
The increasing awareness and acceptance of various fertility treatments among individuals is propelling the market growth. Governing agencies and non-governmental agencies around the world are organizing campaigns that benefit in generating awareness among individuals about the wide availability of treatment options available, which is bolstering the fertility services growth. These campaigns often use media, social platforms, and community outreach to disseminate information about the causes of infertility and the benefits of early intervention. Besides this, publicized instances involving celebrities who candidly talk about their infertility issues and usage of IVF, surrogacy, or egg freezing help to lessen the stigma attached to these procedures. Its visibility inspires others to investigate comparable choices without worrying about being judged by others. Furthermore, major companies in the market are engaging in partnerships and collaborations among major players to expand their services and increase fertility services market revenue. For instance, on 26 April 2023, a nationwide platform for family-building with flexible financing plans and concierge support services 'Future Family (FF)' and Prelude Network(R), a top provider of all-inclusive reproductive services in North America, established an exclusive agreement. The partnership will expand financial accessibility to premium fertility services and empower patients with more financial options and a proper understanding of treatment costs. FF also developed a personalized payment choice tool that allows patients to understand fertility costs based on their individual treatment plans.
Male infertility accounts for the majority of the market share
Male infertility issues can result from a number of factors including bad eating and poor exercise habits. Treatments like intracytoplasmic sperm injection (ICSI), in which a single sperm is injected straight into an egg, are becoming common, especially when it comes to low sperm counts or motility problems. Several medications and hormonal therapies are available to address specific causes of male infertility like hormonal imbalances or infections. These treatments are effective in providing a viable solution to male infertility.
In vitro fertilization with intracytoplasmic sperm injection (IVF with ICSI) holds the largest share of the industry
In vitro fertilization with intracytoplasmic sperm injection (IVF with ICSI) is beneficial in cases of severe male infertility, where traditional IVF methods might not be as effective. It is used to maximize the chances of fertilization among individuals. The growing demand for effective treatments like IVF with ICSI, as people are seeking assisted reproductive technologies (ART) to overcome infertility, is offering a favorable fertility services industry outlook.
Frozen non-donor represents the leading market segment
Frozen non-donor services include the use of frozen eggs or embryos from the intended mother or parents, without the involvement of donors. The preference for frozen non-donor services is likely driven by advancements in cryopreservation techniques, offering higher success rates and flexibility for patients in terms of timing their fertility treatments. Advancements in egg freezing techniques like vitrification are leading to higher survival rates of eggs during the freezing and thawing processes. This makes frozen eggs a more viable option for future fertility treatments and shows fertility services market dynamics.
Fertility clinics exhibit a clear dominance in the market
Fertility clinics offer a wide range of treatments like IVF, ICSI, egg and sperm donation, fertility preservation, and genetic testing. Their ability to provide a full spectrum of services under one roof makes them the go-to option for patients. These clinics often provide personalized treatment plans tailored to the specific needs of each patient, which increases the chances of patient satisfaction. Fertility services market highlights that fertility clinics are focusing on expanding their reach and establishing networks of clinics in various regions, making their services more accessible to a broader population. In addition, these clinics are staffed with experts in reproductive medicine including fertility specialists, embryologists, and genetic counselors, ensuring high-quality care. They are also equipped with the latest technology and lab facilities, which are crucial for performing advanced procedures.
Asia Pacific leads the market, accounting for the largest fertility services market share
The report has also provided a comprehensive analysis of all the major regional markets, which include Europe, North America, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, Asia Pacific represents the largest regional market for fertility services.
Asia Pacific is home to some of the world's most populous countries such as China and India. With a large population, the number of people facing infertility is significant, driving the demand for fertility services. Urbanization, changing lifestyles, delayed marriages, and increasing age of first-time parents are contributing to rising infertility rates among individuals in the region. Moreover, fertility services industry report demonstrates that environmental factors such as pollution and exposure to toxins, play a crucial role. Besides this, governing authorities in the region are encouraging treatment solutions related to infertility. For instance, in 2024, government agencies in Maharashtra launched in-vitro fertilization (IVF) centers in some selected government-run medical colleges and hospitals (GMCH) to provide free treatment to thousands of couples grappling with infertility. The move was made in response to the alarming drop in Maharashtra's total fertility rate (TFR).
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)